Manchester Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History

Manchester Capital Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$433K	Buy	8,110 +610	+8%	+$35.8K	0.06%	181
2025 Q4	$466K	Hold	7,500	–	–	0.06%	173
2025 Q3	$451K	Hold	7,500	–	–	0.06%	206
2025 Q2	$470K	Hold	7,500	–	–	0.06%	217
2025 Q1	$451K	Hold	7,500	–	–	0.06%	213
2024 Q4	$438K	Hold	7,500	–	–	0.05%	211
2024 Q3	$444K	Hold	7,500	–	–	0.05%	214
2024 Q2	$420K	Buy	+7,500	New	+$420K	0.05%	218

Other funds holding IHI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Manchester Capital Management's IHI Position: Q1 2026 in Review

Manchester Capital Management increased its iShares US Medical Devices ETF (IHI) stake by 8.1% in Q1 2026, buying an estimated $35.8K and bringing the position to 8,110 shares worth $433K. The position accounts for 0.06% of the portfolio, ranked #181.

Manchester Capital Management first reported a position in IHI in Q2 2024 and has held it in 8 quarters since. The position peaked at $470K in Q2 2025. 504 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

Manchester Capital Management held 8,110 shares of iShares US Medical Devices ETF worth $433K as of Q1 2026.
Manchester Capital Management bought 610 iShares US Medical Devices ETF shares in Q1 2026, an estimated $35.8K.
iShares US Medical Devices ETF made up 0.06% of Manchester Capital Management's portfolio in Q1 2026, its #181 holding.
Manchester Capital Management first reported a position in iShares US Medical Devices ETF in Q2 2024 and has held it in 8 quarters since.
Manchester Capital Management's iShares US Medical Devices ETF position peaked at $470K in Q2 2025.
504 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.